ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK
46.65
28-March-24 15:59:55
15 minutes delayed
Stocks
-0.17
-0.36%
Today's range
46.28 - 47.12
ISIN
N/A
Source
NASDAQ
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22 Mar 2024 16:00:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Investor Conferences in March
27 Feb 2024 16:30:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
15 Feb 2024 16:01:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 16:00:00 By Nasdaq GlobeNewswire
-
05 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
25 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19 Jan 2024 16:00:00 By Nasdaq GlobeNewswire
-
07 Jan 2024 11:00:00 By Nasdaq GlobeNewswire
-
03 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 Dec 2023 16:30:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Investor Conferences in November
20 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
Ultragenyx to Participate in the Jefferies London Healthcare Conference
07 Nov 2023 17:00:00 By Nasdaq GlobeNewswire
-
Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update
02 Nov 2023 16:05:01 By Nasdaq GlobeNewswire
-
Ultragenyx to Host Conference Call for Third Quarter 2023 Financial Results and Corporate Update
26 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >